Refine by
Holter Monitoring Articles & Analysis
5 news found
Biotres is the Company’s revolutionary technology that represents the future of Remote Patient Monitoring and the delivery of real-time diagnostic data. It serves as a three-lead device designed to continuously record electrocardiogram (ECG) data for early detection of cardiac arrhythmias, disrupting the conventional one-lead patch Holter ...
The Company believes that its wireless, wearable Biotres device offers a secondary product for doctors and hospitals to meet their patients’ cardiac monitoring needs and addresses the $5.7 billion cardiac arrhythmia monitoring devices market. The conventional one-lead patch Holter monitor has been the standard of care for ...
Food and Drug Administration (FDA) for its Biotres Cardiac Monitoring Device, a three lead device for ECG and arrhythmia monitoring that is intended for lower risk patients. ...
A head-to-head peer-reviewed clinical study published in the American Heart Journal comparing the CAM Patch and a traditional Holter monitor, demonstrated that QT, PR and QRS intervals measured by the CAM Patch correlated with measurements taken by a traditional 3-channel (6-lead) Holter monitor, resulting in correlation ...
Patients were assessed for atrial fibrillation with 7-day continuous Holter monitoring at discharge and then 3, 6, and 12 months after the treatment. ...